Handbuch der Klosterheilkunde.Muenchen: Verlag Zabert Sandmann.Mazzanti, G., Di Sotto, A., Franchitto, A., Mammola, C. L., Mariani, P.,Mastrangelo, S., et al. (2009). Chelidonium majus is not hepatotoxic in WistarFrontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 299189Zielin'ska et al. Medicinal Uses of Chelidonium majusrats, in a 4 weeks feeding experiment. J. Ethnopharmacol. 126, 518-524.doi: 10.1016/j.jep.2009.09.004Menale, B., Amato, G., Di Prisco, C., and Muoio, R. (2006). Traditional uses ofplants in North-Western Molise (Central Italy). Delpinoa 48, 29-36.Meng, F., Zuo, G., Hao, X., Wang, G., Xiao, H., Zhang, J., et al. (2009). Antifungalactivity of the benzo [c] phenanthridine alkaloids from Chelidonium majusLinn against resistant clinical yeast isolates. J. Ethnopharmacol. 125, 494-496.doi: 10.1016/j.jep.2009.07.029Menkovic', N., Savikin, K., Tasic', S., Zdunic', G., Stesevic', D., Milosavljevic', S.,et al. (2011). Ethnobotanical study on traditional uses of wild medicinalplants in Prokletije Mountains (Montenegro). J. Ethnopharmacol. 133, 97-107.doi: 10.1016/j.jep.2010.09.008Migas, P., Heyka, M., Poblocka-Olech, L., and Krauze-Baranowska, M. (2012).BMD-TLC -- the useful technique for quantitative analysis of chelidonine,chelerithrine and berberine in herbal drugs. J. Planar. Chromatogr. 25, 439-444.doi: 10.1556/JPC.25.2012.5.9Mikolajczak, P. L., Kedzia, B., Ozarowski, M., Kujawski, R., Bogacz, A.,Bartkowiak-Wieczorek, J., et al. (2015). Evaluation of anti-inflammatory andanalgesic activities of extracts from herb of Chelidonium majus L. Cent. Eur. J.Immunol. 40, 400-410. doi: 10.5114/ceji.2015.54607Mitra, S., Sur, R. K., Roy, A., and Mukherjee, A. S. (1996). Effect of Chelidoniummajus L. on experimental hepatic tissue injury. Phytother Res. 10, 354-356.Moricz, A. M., Fornal, E., Jesionek, W., Majer-Dziedzic, B., and Choma,I. M. (2015). Effect-directed isolation and identification of antibacterialChelidonium majus L. Alkaloids. Chromatographia 78, 707-716.doi: 10.1007/s10337-015-2870-6Moricz, A. M., Ott, P. G., Yuce, I., Darcsi, A., Beni, S., and Morlock, G. E.(2018). Effect-directed analysis via hyphenated high-performance thin-layerchromatography for bioanalytical profiling of sunflower leaves. J. Chromatogr.A. 19, 213-220. doi: 10.1016/j.chroma.2017.12.034Mustafa, B., Hajdari, A., Pajazita, Q., Syla, B., Quave, C. L., and Pieroni, A. (2012).An ethnobotanical survey of the Gollak region, Kosovo. Genet. Resour. Crop.Evol. 59, 739-754. doi: 10.1007/s10722-011-9715-4Nadova, S., Miadokova, E., Alfoldiova, L., Kopaskova, M., Hasplova, K.,Hudecova, A., et al. (2008). Potential antioxidant activity, cytotoxic andapoptosis-inducing effects of Chelidonium majus L. extract on leukemia cells.Neuroendocrinol. Lett. 29, 649-652.Nawrot, R., Barylski, J., Lippmann, R., Altschmied, L., and Mock, H. P. (2016).Combination of transcriptomic and proteomic approaches helps to unravelthe protein composition of Chelidonium majus L. milky sap. Planta 244,1055-1064. doi: 10.1007/s00425-016-2566-7Nawrot, R., Kalinowski, A., and Gozdzicka-Jozefiak, A. (2007a). Proteomicanalysis of Chelidonium majus milky sap using two-dimensional gelelectrophoresis and tandemmass spectrometry. Phytochemistry 68, 1612-1622.doi: 10.1016/j.phytochem.2007.03.039Nawrot, R., Lesniewicz, K., Pienkowska, J., and Gozdzicka-Jozefiak, A. (2007b). Anovel extracellular peroxidase and nucleases from a milky sap of Chelidoniummajus. Fitoterapia 78, 496-501. doi: 10.1016/j.fitote.2007.04.012Nawrot, R., Tomaszewski, L., Czerwoniec, A., and Gozdzicka-Jozefiak, A. (2013).Identification of a coding sequence and structure modeling of a Glycine-RichRNA-Binding Protein (CmGRP1) from Chelidonium majus L. Plant Mol. Biol.Rep. 31, 470-476. doi: 10.1007/s11105-012-0510-yNawrot, R., Wolun-Cholewa, M., and Gozdzicka-Jozefiak, A. (2008). Nucleasesisolated from Chelidonium majus L. milky sap can induce apoptosis in humancervical carcinoma HeLa cells but not in Chinese Hamster Ovary CHO cells.Folia Histochem. Cytobiol. 46, 79-83. doi: 10.2478/v10042-008-0011-xNawrot, R., Zauber, H., and Schulze, W. X. (2014). Global proteomicanalysis of Chelidonium majus and Corydalis cava (Papaveraceae) extractsrevealed similar defense-related protein compositions. Fitoterapia 94, 77-87.doi: 10.1016/j.fitote.2014.01.015Nawrot, R., Jozefiak, D., Sip, A., Kuzma, D., Musidlak, O., Gozdzicka-Jozefiak, A.,et al. (2017a). Isolation and characterization of a non-specific lipid transferprotein from Chelidonium majus L. latex. Int. J. Biol. Macromol. 104(Pt A),554-563. doi: 10.1016/j.ijbiomac.2017.06.057Nawrot, R., Lippmann, R., Matros, A., Musidlak, O., Nowicki, G., and Mock,H. P. (2017b). Proteomic comparison of Chelidonium majus L. latex indifferent phases of plant development. Plant Physiol. Biochem. 112, 312-325.doi: 10.1016/j.plaphy.2017.01.010NecVas, M., Dostal, J., Kejnovska, I., VorlicVkova, M., and Slavik, J. (2005). Molecularand crystal structures of (+)-homochelidonine, (+)-chelamine, and (-)-norchelidonine. J. Mol. Struct. 734, 1-6. doi: 10.1016/j.molstruc.2004.08.006Niu, C.-Q., and He, L.-Y. (1994). Determination of isoquinoline alkaloids inChelidonium majus L. by ion-pair high-performance liquid chromatography.J. Chromatogr. A 542, 193-199.Niu, X. F., Zhou, P., Li, W. F., and Xu, H. B. (2011). Effects of chelerythrine,a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice.Fitoterapia 82, 620-625. doi: 10.1016/j.fitote.2011.01.020Noureini, S. K., Esmaeili, H., Abachi, F., Khiali, S., Islam, B., Kuta, M., et al. (2017).Selectivity of major isoquinoline alkaloids from Chelidonium majus towardstelomeric G-quadruplex: a study using a transition-FRET (t-FRET) assay.Biochim. Biophys. Acta. 1861, 2020-2030. doi: 10.1016/j.bbagen.2017.05.002Noureini, S. K., and Wink, M. (2009). Transcriptional down regulation ofhTERT and senescence induction in HepG2 cells by chelidonine. World J.Gastroenterol. 15, 3603-3610. doi: 10.3748/wjg.15.3603Nowicky, W. (2001). Clinical testing of Ukrain R(c). Lancet Oncol. 2:10.doi: 10.1016/S1470-2045(00)00188-1Oh, H.-A., Kim, H.-M., and Jeong, H.-J. (2011). Beneficial effects of chelidonicacid on a model of allergic rhinitis. Int. Immunopharmacol. 11, 39-45.doi: 10.1016/j.intimp.2010.10.002Orland, A., Knapp, K., Konig, G. M., Ulrich-Merzenich, G., and Knoss, W.(2014). Combining metabolomic analysis and microarray gene expressionanalysis in the characterization of the medicinal plant Chelidonium majus L.Phytomedicine 21, 1587-1596. doi: 10.1016/j.phymed.2014.07.012Osbaldeston, T. A., and Wood, R. P. A. (2000). Dioscorides de Materia Medica,Being a Herbal with Many other Materials Written in Greek in the FirstCentury of the Common Era. An Indexed Version in Modern English; Book 2.Johannesburg: Ibidis Press, 352-355.Pantano, F., Mannocchi, G., Marinelli, E., Gentili, S., Graziano, S., Busardo, F. P.,et al. (2017). Hepatotoxicity induced by greater celandine (Chelidonium majusL. ): a review of the literature. Eur. Rev. Med. Pharmacol. Sci. 21, 46-52.Panzer, A., Joubert, A. M., Eloff, J. N., Albrecht, C. F., Erasmus, E., and Seegers, J.C. (2000). Chemical analyses of Ukrain R(c)(TM), a semi-synthetic Chelidoniummajus alkaloid derivative, fail to confirm its trimeric structure. Cancer Lett. 160,237-241. doi: 10.1016/S0304-3835(00)00595-4Panzer, A., Joubert, A. M., Bianchi, P. C., and Seegers, J. C. (2001). Theantimitotic effects of Ukrain R(c)(TM), a Chelidonium majus alkaloid derivative,are reversible in vitro. Cancer Lett. 150, 85-92. doi: 10.1016/S0304-3835(99)00375-4Park, J. E., Cuong, T. D., Hung, T. M., Lee, I., Na, M., Kim, J. C., et al. (2011).Alkaloids from Chelidonium majus and their inhibitory effects on LPS-inducedNO production in RAW264.7 cells. Bioorg. Med. Chem. Lett. 21, 6960-6963.doi: 10.1016/j.bmcl.2011.09.128Paul, A., Das, j., Das, S., Samadder, A., and Khuda-Bukhsh, A. R.(2013). Poly (lactide-coglycolide) nano-encapsulation of chelidonine,an active bioingredient of greater celandine (Chelidonium majus),enhances its ameliorative potential against cadmium induced oxidativestress and hepatic injury in mice. Envir. Toxicol. Phar. 36, 937-947.doi: 10.1016/j.etap.2013.08.008Paulsen, J., Yahyazadeh, M., Hansel, S., Kleinwachter, M., Ibrom, K., and Selmar,D. (2015). 13,14-Dihydrocoptisine - The genuine alkaloid from Chelidoniummajus. Phytochemistry 111, 149-153. doi: 10.1016/j.phytochem.2015.01.006Pavao, M. L., and Pinto, R. E. (1995). Densitometric assays for the evaluation ofwater soluble alkaloids from Chelidonium majus L. (Papaveraceae) roots in theAzores, along one year cycle. Arquipelago 13, 85-91.Pepeljnjak, S., Kosalec, I., Kalodera, Z., and Kustrak, D. (2003). "Naturalantimycotics from Croatia plants" in Plant- Derived Antimycotics. CurrentTrends and Future Prospects, eds M. Rai and D. Mares (New York, NY: FoodProducts Press), 49-79.Petruczynik, A., Gadzikowska, M., and Waksmundzka-Hajnos, M. (2002).Optimization of the separation of some Chelidonium maius L. alkaloids byreversed phase high-performance liquid chromatography using cyanopropylbonded stationary phase. Acta Pol. Pharm. 59, 61-64.Petruczynik, A., Waksmundzka-Hajnos, M., Michniowski, T., Plech, T., Tuzimski,T., Hajnos, M. L., et al. (2007). Thin-Layer Chromatography of Alkaloids onCyanopropyl Bonded Stationary Phases. Part I. J. Chromatogr. Sci. 45, 447-454.doi: 10.1093/chromsci/45.7.447Frontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 299190Zielin'ska et al. Medicinal Uses of Chelidonium majusPetruczynik, A., Waksmundzka-Hajnos, M., Plech, T., Tuzimski, T., Hajnos, M. L.,Jozwiak, G., et al. (2008). TLC of Alkaloids on Cyanopropyl Bonded StationaryPhases. Part II. Connection with RP18 and Silica Plates. J. Chromatogr. Sci. 46,291-297. doi: 10.1093/chromsci/46.4.291Philchenkov, A., Kaminskyy, V., Zavelevich, M., and Stoika, R. (2008).Apoptogenic activity of two benzophenanthridine alkaloids from Chelidoniummajus L. does not correlate with their DNA damaging effects. Toxicol. In Vitro22, 287-295. doi: 10.1016/j.tiv.2007.08.023Pieroni, A., Dibra, B., Grishaj, G., Grishaj, I., and Macai, S. (2005). Traditionalpytotherapy of the Albanians of Lepushe, Northern Albanian Alps. Fitoterapia76, 379- 399. doi: 10.1016/j.fitote.2005.03.015Pieroni, A., and Gray, C. (2008). Herbal and Food Folk Medicines of theRusslanddeutschen living in Kunzelsau/ Talacker, South-Western Germany.Phytother. Res. 22, 889-901. doi: 10.1002/ptr.2410Poormazaheri, H., Baghban, K., Khosravi, D. N., Naghavi, M., Kalantar, E.,Mohammadkhani, E., et al. (2017). High-content analysis of chelidonineand berberine from Iranian Chelidonium majus L. ecotypes in differentontogenetical stages using various methods of extraction. J. Agric. Sci.